Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine (Q40393089)

https://doi.org/10.1038/sj.cr.7290378

20 September 2017

1 reference

29 December 2023

title

Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine (English)

1 reference

20 September 2017

0 references

Soldano Ferrone

1 reference

20 September 2017

Wei Hua Yan

1 reference

20 September 2017

Ai Fen Lin

series ordinal

1 reference

20 September 2017

Chien Chung Chang

series ordinal

1 reference

20 September 2017

publication date

1 July 2005

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

523-531

1 reference

HLA-G: a shield against inflammatory aggression

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G modulates immune responses by diverse receptor interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G gene activation in tumor cells involves cis-acting epigenetic changes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G in melanoma: can the current controversies be solved?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G gene repression is reversed by demethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Nonclassical HLA-G molecules are classical peptide presenters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Empty MHC class I molecules come out in the cold

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Biology and functions of human leukocyte antigen-G in health and sickness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

HLA-G in cancer: a way to turn off the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Major histocompatibility complex class I-restricted antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Recent developments in MHC-class-I-mediated antigen presentation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290376

7 January 2021

Identifiers

DOI

10.1038/SJ.CR.7290376

1 reference

Dimensions Publication ID

20 September 2017

1005056197

0 references

1 reference